These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6421089)

  • 21. Pharmacokinetics and metabolism of ftorafur in man.
    Au JL; Wu AT; Friedman MA; Sadée W
    Cancer Treat Rep; 1979 Mar; 63(3):343-50. PubMed ID: 371796
    [No Abstract]   [Full Text] [Related]  

  • 22. Quantitative gas-liquid chromatographic determination of ftorafur and 5-fluorouracil in biological specimens.
    Pantarotto C; Fanelli R; Filippeschi S; Facchinetti T; Spreafico F; Salmona M
    Anal Biochem; 1979 Sep; 97(2):232-8. PubMed ID: 393130
    [No Abstract]   [Full Text] [Related]  

  • 23. [A randomized study on the long-term adjuvant chemotherapy with ftorafur and mitomycin C for gastric cancer: the second study (III)].
    Muto T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Akiyama H; Abe O; Nakajima T; Kikuchi K
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1863-70. PubMed ID: 6433808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum concentrations of 5-FU, ftorafur, and a major serum metabolite following ftorafur chemotherapy.
    Hornbeck CL; Griffiths JC; Floyd RA; Ginther NC; Byfield JE; Sharp TR
    Cancer Treat Rep; 1981; 65(1-2):69-72. PubMed ID: 6784923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for toxicologic activity of ftorafur independent of conversion to 5-fluorouracil.
    Harrison SD; Denine EP; Giles HD
    Cancer Treat Rep; 1979 Aug; 63(8):1389-91. PubMed ID: 383294
    [No Abstract]   [Full Text] [Related]  

  • 26. [In vitro diffusion of 5-fluorourcil and tegafur through excized pig cornea].
    Grześkowiak E
    J Pharm Belg; 1997; 52(5):190-3. PubMed ID: 9432527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicologic and therapeutic examinations with ftorafur in different mouse strains.
    Fichtner I; Arnold W; Naundorf H
    Neoplasma; 1981; 28(2):133-40. PubMed ID: 6789219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ftorafur in the treatment of advanced malignancies.
    Shetty PA; De Souza LJ; Jussawalla DJ
    Indian J Cancer; 1982; 19(3):159-60. PubMed ID: 6816720
    [No Abstract]   [Full Text] [Related]  

  • 29. Sensitive MS/MS-liquid chromatography assay for simultaneous determination of tegafur, 5-fluorouracil and 5-fluorodihydrouracil in plasma.
    Remaud G; Boisdron-Celle M; Morel A; Gamelin A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):153-60. PubMed ID: 16061432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analytical study of ftorafur-N 1-(2'-furanidil)-5-fluorouratil].
    Tománková H; Kucerová E
    Cesk Farm; 1977 Apr; 26(3):97-100. PubMed ID: 326428
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and biological activities of ftorafur metabolites. 3'- and 4'-hydroxyftorafur.
    Lin AJ; Benjamin RS; Rao PN; Loo TL
    J Med Chem; 1979 Sep; 22(9):1096-100. PubMed ID: 385879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolism of ftorafur in the beagle dog and rhesus monkey.
    Freudenthal RI; Emmerling DC
    Xenobiotica; 1977 Dec; 7(12):757-64. PubMed ID: 414463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-pressure liquid chromatographic analysis of ftorafur and its metabolites in biological fluids.
    Benvenuto JA; Lu K; Loo TL
    J Chromatogr; 1977 Apr; 134(1):219-22. PubMed ID: 323272
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ftorafur interaction with biopolymers].
    Sharimanov IuG; Liubas B; Vechorkevich T; Dzhandzhaliia MV
    Biofizika; 1984; 29(2):207-11. PubMed ID: 6426528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil.
    Kato T; Shimamoto Y; Uchida J; Ohshimo H; Abe M; Shirasaka T; Fukushima M
    Anticancer Res; 2001; 21(3B):1705-12. PubMed ID: 11497250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experimental study of the efficacy of ftorafur phonophoresis in simulated allergic uveitis].
    Smaliukh NV
    Oftalmol Zh; 1983; (7):397-9. PubMed ID: 6420738
    [No Abstract]   [Full Text] [Related]  

  • 37. Involvement of microsomal cytochrome P450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver.
    Komatsu T; Yamazaki H; Shimada N; Nagayama S; Kawaguchi Y; Nakajima M; Yokoi T
    Clin Cancer Res; 2001 Mar; 7(3):675-81. PubMed ID: 11297264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological compatibility of the antineoplastic drugs ftorafur and 5-fluorouracil with the psychotropic drugs aminazine and phenazepam (an experimental study)].
    Syrkin AB; Voronia TA; Mikhaĭlova LM; Suslov NI
    Vestn Akad Med Nauk SSSR; 1984; (5):66-70. PubMed ID: 6429964
    [No Abstract]   [Full Text] [Related]  

  • 39. A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958).
    Friedman MA; Ignoffo RJ
    Cancer Treat Rev; 1980 Dec; 7(4):205-13. PubMed ID: 6783303
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential effects of 5-fluorouracil analogs on humoral and cell-mediated responses in mice: augmentation of delayed hypersensitivity response against picryl chloride by 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione (FD-1), a new anti-tumor drug.
    Yamada Y; Miyauchi S; Unemi N
    J Clin Lab Immunol; 1980 Nov; 4(3):153-7. PubMed ID: 6451710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.